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ABSTRACT 
The purpose of this study was to evaluate whether hydrotherapy programmes improve exercise tolerance and quality of life in 
patients with chronic heart failure. Data sources utilised were EBSCO, Scopus, Medline, PubMed, OVID, Proquest, PEDro and 
Cochrane Systematic Reviews databases.  A systematic review of randomised controlled trials or quasi randomised controlled trials 
investigated hydrotherapy compared with a suitable control. Methodological quality was assessed using a modified version of 
the Downs and Black critical appraisal tool. Findings demonstrated that hydrotherapy was well tolerated with few adverse events 
reported.  Two studies demonstrated hydrotherapy intervention groups significantly improved 6MWT from baseline (p≤0.05), 
while two studies found significantly greater improvements when compared to non-exercising (p=0.01) and land based exercising 
(p=0.001) controls.  Four studies found significant gains (p≤0.05) in VO
2
 peak from baseline following hydrotherapy interventions.  
Two studies reported significant (p=0.01) intragroup improvements in total score of the Minnesota Living with Heart Failure 
Questionnaire in hydrotherapy intervention groups when compared with baseline and a non-exercising control respectively. In 
conclusion, hydrotherapy exercise programmes were well tolerated and appear to improve exercise capacity and quality of life in 
people with chronic heart failure but firm conclusions could not be drawn due to the poor to moderate quality of the evidence.   
Graetz B, Sullivan M, Robertson T, Reeve J (2015) Do hydrotherapy exercise programmes improve exercise tolerance and quality 
of life in patients with chronic heart failure? A systematic review New Zealand Journal of Physiotherapy 43(2): 64-71. DOI: 
10.15619/NZJP/43.2.07 
 
INTRODUCTION
Chronic heart failure (CHF) is an inability of the heart to deliver 
adequate oxygen to metabolising tissues (NZ Heart Foundation 
2009).  This occurs as a result of changes in cardiac structure and/
or function, and is most commonly caused by coronary artery 
disease (including myocardial infarction), valvular disease and cardiac 
myopathy (Carvalho and Guimaraes 2010).  This has implications for 
patient function, as any increase in oxygen demand that occurs with 
an increase in activity may not be met.  As a result, people with CHF 
often experience an increase in symptoms of breathlessness and 
fatigue and a resultant reduction in exercise tolerance and quality 
of life (Somaratne et al 2009).   While there is no single diagnostic 
test for CHF, the New York Heart Association (NYHA) scale classifies 
the progression of CHF based on a patient’s symptomatic status and 
exercise capacity (Yancy et al 2013).  The stages range from stage 
1 (No limitation of physical activity) through to stage 4 (Unable to 
carry out any physical activity without symptoms of HF or symptoms 
of HF at rest) (American Heart Association 2014).  Exercise-based 
rehabilitation improves symptoms of CHF by improving peripheral 
haemodynamic and physiological efficiency, thus reducing 
cardiovascular demands (Piepoli et al 2010).  Cardiac rehabilitation 
programmes have been shown to reduce disease affected life years 
and hospital admissions in patients with CHF (Taylor et al 2014).  As 
such, exercise based cardiac rehabilitation programmes have proven 
benefits on personal and likely economic levels.
Cardiovascular disease has been identified as a health priority 
in New Zealand, due to its significant burden on the annual 
healthcare budget (NZ Heart Foundation 2009).  In New 
Zealand, there are more than five thousand patients living 
with CHF, resulting in 12,000 hospitalisations per year.  As a 
result, CHF accounts for approximately 2% of total health care 
expenditure each year (NZ Heart Foundation 2009).  Treatment 
of CHF typically includes a combination of pharmaceutical 
management and physical rehabilitation (Mant et al 2011).  
CHF is prevalent in the older population (Go et al 2013), with 
this demographic exhibiting a high proportion of physical co-
morbidities (Wong et al 2011).  This may present challenges 
for medical management, and barriers to land-based exercise 
interventions.  As such, alternative modes of exercise, such as 
hydrotherapy, may be useful in overcoming such barriers to 
land-based programmes.
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Hydrotherapy has been used since the early Greco-Roman 
era as a treatment for ailments and illness (Bender et al 
2005).  In modern times, hydrotherapy has been shown to 
be useful in improving functional outcomes for patients with 
chronic neurologic and musculoskeletal conditions, including 
osteoarthritis (Kamioka et al 2010).  However, the literature 
surrounding hydrotherapy for cardiac conditions is still in its 
infancy.  To the authors’ knowledge, at the time of undertaking 
this review, the evidence for hydrotherapy as an alternative 
form of exercise for patients with CHF had not been reviewed. 
Therefore, the aim of this study was to systematically review the 
literature to determine the effects of hydrotherapy programmes 
on exercise tolerance and quality of life in patients with CHF.
METHODS
A systematic review of the literature to ascertain the efficacy of 
aquatic-based exercise on exercise tolerance and health related 
quality of life (HRQOL) was undertaken.  The Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guideline was utilised in undertaking this systematic review.  
The PRISMA guideline was developed to improve standards of 
reporting meta-analyses and systematic reviews (Moher et al 
2010).  Undertaking a meta analysis of the data was deemed 
beyond the scope of this project.
Data sources and search strategy
The electronic databases of EBSCO, Scopus, Medline, PubMed, 
OVID, Proquest, PEDro and Cochrane Systematic Reviews were 
searched over a period from March 2014 to April 2014.  These 
databases were chosen based on their inclusion of allied health 
and medical journals, and those that contain studies relevant 
to exercise-based rehabilitation.  The search terms included 
“hydrotherapy”, “immersion therapy”, “aquatic exercise” and 
for the intervention including “heart failure”.   A full keyword 
search strategy has been included in Appendix A.
Inclusion criteria
Studies were eligible for inclusion if they were randomised 
controlled trials or quasi-experimental trials comparing a water-
based exercise programme to a suitable control.    To be eligible 
for inclusion, studies must have examined the effect of water-
based activity on exercise tolerance and HRQOL in patients with 
CHF.  Studies were excluded if participants did not perform any 
movement in water.  The participants had to be human, and 
have a diagnosis of stable CHF, with a NYHF classification of two 
to three.  A full list of inclusion and exclusion criteria has been 
included in Appendix B. 
Two researchers (BG and MS) concurrently applied the inclusion 
and exclusion criteria to all studies that were retrieved.   Both 
researchers participated in all stages of the screening process, 
including title, abstract and full text screening.  Any studies that 
clearly did not meet the criteria were eliminated.  For any studies 
that were not clear, the abstract and/or full text was retrieved 
for analysis. Both researchers agreed on all studies included 
in this review by consensus, without the need for mediation.  
Both BG and MS screened all included studies for any further 
appropriate studies.
Data extraction and quality assessment
Eligible studies were assessed for methodological quality using a 
modified version of the Downs and Black checklist (Downs and 
Black 1998).  This checklist consists of 27 questions that can be 
applied to experimental or observational studies.   Each question 
is allocated a score of 0, 1 or 2, with higher scores indicating a 
higher overall quality of study. The checklist has been shown to 
be a valid and reliable tool for the assessment of experimental 
trials.  The checklist was applied to all studies included in this 
review by two assessors (BG and MS) independently.   Results 
of both independent evaluations were compared, and any 
discrepancies were discussed until a consensus was reached. 
RESULTS
Literature search
Database searching yielded a total of 1616 potential studies to 
be included in this review.  Duplicates were removed (n=178) 
and an initial title screening resulted in the exclusion of 1438 
titles.  Following the abstract and full text screening process, 
six studies were identified to be included in the final analysis 
(Caminiti et al 2009, Cider et al 2003, Cider et al 2012, Mourot 
et al 2010, Munincino et al 2006, Teffaha et al 2011).  The 
process of study selection, elimination and reasons for exclusion 
is included in Figure 1. 
Summary of included studies
Methodological quality assessment
The methodological quality of studies ranged from poor (9/28) 
to moderate (20/28).  All studies failed to blind participants 
and assessors, and all studies failed to report an adjustment for 
confounding factors in their data analysis.  Total scores for each 
of the included studies are presented in Table 1.
Study design
Of the six studies that met the inclusion criteria, four were 
randomised controlled trials (Caminiti et al 2009, Cider et 
al 2003, Cider et al 2012, Teffaha et al 2011).  Two studies 
compared hydrotherapy to land based exercise programmes 
(Caminiti et al 2009, Teffaha et al 2011). Cider et al (2003, 
2012) compared hydrotherapy to usual care (no increase in 
habitual physical activity) and two studies were feasibility studies 
of repeated measures design, in which the participants served 
as their own controls (Mourot et al 2010, Municino et al 2006).  
Details of the programme, participants, intervention and control 
groups are outlined in Table 2. 
Figure 1: Search Strategy Flow Chart
Electronic search of EBSCO, 
Scopus, Medline, Proquest, 
Ovid, PEDro, Cochrane 
Articles retrieved (n=1616) 
Duplicates removed (n=158) 
Title exclusion (n=1418) 
Abstracts reviewed (n=40) 
Excluded (n=27): 
Not human (n=9) 
Not clinical trial (n=10) 
Not in English (n=4)  
Not hydrotherapy (n=4) 
Full text reviewed (n=13) 
Excluded (n=7): 
Wrong patient group (n=2) 
Wrong study design (n=2) 
Wrong outcome measure (n=1) 
Not English (n=1) 
Wrong intervention (n=1)  
Met inclusion criteria (n=6) 
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Study
Participants Intervention
Main Findings
Experimental Control Experimental
Control
Caminiti et al 
(2009)
n=11
M/F: 11/0
*Age: 67 (6)
NYHA II = 7
NYHA III = 4
n=10
M/F: 10/0
*Age: 69 (8)
NYHA II = 6
NYHA III = 4
24-week programme: 
Combined endurance 
training and 
hydrotherapy; 1-hr, 3 x 
per week
No intensity specified
24 weeks - 
Endurance training 
only; 1-hr, 3 x per 
week for (60-70% 
VO
2 max
)
Combined group 
significantly improved 
6MWT compared to 
baseline and land-based 
controls (p<.001)
Cider 
(2003)
n=15
M/F: 11/5
*Age: 70.2 (5.2)
NYHA II = 3
NYHA III = 12
n=10
M/F: 6/3
*Age: 75 (6.4)
NYHA II = 1
NYHA III = 9
8-week programme: 
45 min, 3 x per week.  
Low to moderate exercise 
level (40-70%HRR)
Live life as usual, no 
increase in habitual 
physical activity
No significant findings 
from baseline or between 
groups for aerobic 
capacity outcome 
measures.
Significantly improved 
MLHFQ total score, but 
not more than controls
Cider 
(2012)
n=10
M/F: 8/2
*Age:  65.8 (5.8)
NYHA II = 5
NYHA III = 5
n=10
M/F: 8/2
*Age: 69 (8.2)
NYHA II = 3
NYHA III = 7
8-week programme: 
45 min, 3 x per week.  
Low to moderate exercise 
level (40-75%HRR)
Live life as usual, no 
increase in habitual 
physical activity
Improved VO
2peak
 and 
6MWT compared to 
controls (p<.01)
No significant between-
group differences in 
HRQOL outcomes
Mourot et al 
(2010)
n=24
M/F: 24/0
*Age: 53 (4)
NYHA: Not 
reported
CHF = 12
CAD = 12
Own control
3-week programme : 
Water-based gymnastic 
exercises, 40 min, 3-4 x 
per week
Land-based endurance 
exercise (exercycle), 30 
min, 4-5 x per week @ 
60-70% HRR)
Own control – 
all participants 
measured pre and 
post-intervention
Significantly improved 
VO
2peak
  from baseline 
(p<.05)
Municino et al 
(2006)
n=18
M/F: 7/1
*Age: 63 (10)
NYHA II = 9
NYHA III = 7 
NYHA IV = 2
Own control
3-week programme:  
2 x 30-50 min 
hydrotherapy sessions 
per day.  
Educational and psycho-
behavioural support 
sessions 5 x per week.  
Own control – 
all  participants  
measured pre and 
post-intervention
Significant improvements 
in 6MWT, VO
2peak
 and 
MLHFQ from baseline 
(p<.05).
Teffaha et al
(2011)  
n= 24
M/F: 24/0
*Age: 51.7 (3.6)
CHF NYHA II = 1
CHF NYHA III 
= 11
CAD NYHA II 
= 12
n  =  24
M/F: 24/0
*Age: 53.3 (4.2)
CHF NYHA II = 2
CHF NYHA III = 10
CAD NYHA II = 12
3-week programme: 
5 x per week, 35 min
Endurance and water 
calisthenics
Individualised target 
intensity based on initial 
testing
3-week programme: 
5 x per week, 35 min
Land-based 
endurance and 
calisthenics
Individualised target 
intensity based on 
initial testing
Hydrotherapy  CHF group 
improved VO
2peak
 from 
baseline, and significantly 
more than land-based 
control (p<.05)
Note: * Age is mean (standard deviation); M, male; F, female; NYHA, New York Heart Association;  VO
2 max
, maximal oxygen uptake; HRR, heart rate reserve; CHF, 
chronic heart failure; CAD, coronary artery disease; 6MWT, Six Minute Walk Test;  HRQOL, Health Related Quality of Life; MLHFQ, Minnesota Living with Heart failure 
questionnaire; VO
2peak, 
peak oxygen uptake. 
Table 2:  Study Summary and Results
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Participants
Across all studies, a total of 174 participants with CHF were 
investigated, of whom 18 were female.  The mean age of all 
participants was 63.5 years.  Patients were included in all studies 
based on a clinical diagnosis of CHF.  All studies apart from 
Mourot et al (2010) reported NYHF classification, primarily of 
II-III, however one study (Municino et al 2006) included two 
participants of NYHA IV.  All studies reported left ventricular 
ejection fraction (LVEF) of ≤45%.  Participants were excluded if 
they had unstable CHF, peripheral artery disease, fear of water, 
any contraindications to exercise testing or disabling diseases 
that may have interfered with the exercise protocol.
Programme components
Duration: Programmes ranged from three to 24 weeks.  Three 
of the six studies extended over eight or more weeks (Caminiti 
et al 2009, Cider et al 2003, Cider et al 2012).  Three studies 
were conducted over three weeks (Mourot et al 2010, Municino 
et al 2006, Teffaha et al 2011).  Exercise sessions ranged from 
30 to 50 minutes, with session frequency ranging from twice 
weekly to two sessions daily five times per week.  Details of the 
programme components have been outlined in Table 2.
Location/water temperature:  Programmes were carried out in 
hospital rehabilitation pools across Europe - in Sweden (Cider et al 
2003, Cider et al 2012), France (Mourot et al 2010, Teffaha et al 
2011) or in Italy (Caminiti et al 2009, Municino et al 2006).  Water 
temperature was set between 31-34 degrees Celsius for all studies. 
Intensity: Intensity was reported across all studies as a target 
heart rate reserve (HRR) or as a percentage of VO2peak.  Target 
heart rate ranged from 40-70% HRR in three studies (Cider 
et al 2003, Cider et al 2012, Mourot et al 2010).  Two studies 
measured intensity using results of oxygen consumption testing 
or VO
2peak 
(Municino et al 2006 a, Teffaha et al 2011).  The 
target VO
2
 in these studies ranged from 40-70% VO
2peak/max
.  
One study (Caminiti et al 2009) did not identify specific target 
intensities, instead reporting that a target VO
2
 was individualised 
to the patient based on initial testing.
Adverse events:  Three patients (intervention group) across two 
studies were withdrawn from the programme due to: peripheral 
ulcer (n=1), increase in CHF symptoms (n=1) (Cider et al 2012) 
and the recurrence of a preexisting cardiac arrhythmia (n=1) 
(Cider et al 2003). No other adverse events were reported. One 
study failed to report adverse events (Mourot et al 2010).  
Adherence: Across all studies one participant withdrew 
themselves from the programme due to family problems (Cider 
et al 2012).  One study (Mourot et al 2010) failed to report 
adherence.  One study (Teffaha et al 2011) reported two 
temporary withdrawals due to bronchopulmonary infection 
(n=1) and medication mismanagement (n=1).  Both patients 
resumed the programme after a one-week absence, completing 
the programme without any complications. 
Outcomes – measures of exercise tolerance 
Six-minute walk test: The six-minute walk test (6MWT) was used 
to measure functional exercise capacity in four studies (Caminiti et 
al 2009, Cider et al 2003, Cider et al 2012, Municino et al 2006).  
Two studies (Caminiti et al 2009, Municino et al 2006) found that 
hydrotherapy intervention groups significantly improved their 
6MWT from baseline (p≤0.05), with Caminiti et al (2009) finding 
significantly greater improvements compared to a land-based 
exercise group (p=0.001).  A third study (Cider et al 2012) found 
significantly improved 6MWT in a hydrotherapy intervention group 
compared with a usual activity control group (p=0.01), which 
consisted of land based participants not permitted to increase their 
usual level of daily physical activity.  Two studies (Cider et al 2003, 
Munincino et al 2006) recorded gains in 6MWT of 29.7m, and 
118m, respectively, whilst one study (Caminiti et al 2009) recorded 
improvements of 150m when compared to baseline and 37m 
when compared to a land based exercise group.  Cider et al (2012) 
reported significant gains in 6MWT in the hydrotherapy group 
versus a usual activity control group, however actual distances were 
not reported.  A summary of these findings is provided in Table 2.
Oxygen consumption: Five studies investigated exercise 
tolerance by measuring peak oxygen uptake (VO2peak) during 
a cycle ergometry test (Cider et al 2003, Cider et al 2012, 
Mourot et al 2010, Municino et al 2006, Teffaha et al 2011).  
Four studies (Cider et al 2012, Mourot et al 2010, Municino 
et al 2006, Teffaha et al 2011) found significant gains from 
baseline following hydrotherapy interventions, with one of these 
intervention groups improving significantly more than usual-
activity controls (Cider et al 2012).  Improvements in VO
2peak
 
ranged from 1.0 to 2.1 mL·kg-1· min-1 across the five studies.
Outcomes – measures of health related quality of life
Health Related Quality of Life Questionnaires: Health related 
quality of life (HRQOL) was investigated in three studies using 
the Minnesota Living with Heart Failure Questionnaire (MLHFQ) 
(Cider et al 2003, Cider et al 2012, Municino et al 2006) and the 
SF-36 (Cider et al 2003, 2012).  Anxiety and depression were 
measured by the Hospital Anxiety and Depression Scale in one 
study (Cider et al 2012). Significant within group improvements 
were found in two of these studies for the combined total of 
MLHFQ total score (Cider et al 2003, Municino et al 2006) and 
physical domain (Cider et al 2003).  One study (Cider et al 2012) 
did not find any significant improvements in total MLHFQ scores 
compared to baseline or control.   This study did find significant 
results following hydrotherapy intervention compared with a 
healthy Swedish reference population with significantly lower 
SF-36 scores across all domains except bodily pain (p<0.05).
DISCUSSION
Hydrotherapy has been proposed as an alternative to traditional 
land-based exercise programmes for people with CHF, however the 
literature surrounding hydrotherapy as an effective intervention for 
this patient group is still in its infancy.  Regular physical activity is 
advocated in patients with chronic heart failure (CHF), due to proven 
benefits in patient function (Selig et al 2010).  Several high-quality 
randomised controlled trials have shown that regular exercise leads 
to improvements in exercise tolerance (Piepoli et al 2010, Taylor et al 
2014) and quality of life (Garin et al 2009, Taylor et al 2014), as well 
as reducing hospital admissions and mortality rates in CHF patients 
of either reduced or preserved ejection fraction and NYHA class 
II-III when compared with no exercise controls (Taylor et al 2014).  
These benefits are thought to arise from peripheral adaptations, 
such as improved vascularity and metabolic adaptation in skeletal 
muscle cells, allowing for increased energy production and improved 
metabolic efficiency (Piepoli et al 2010).   In the present systematic 
review, we identified six studies comparing hydrotherapy versus no 
exercise or land-based exercise training in people with stable CHF, 
with the aim of determining the effects of hydrotherapy on exercise 
tolerance and quality of life in this patient group.
It has been proposed that the resistance of hydrostatic pressure 
when moving through water may deliver a greater training 
stimulus than land-based exercise (Becker 2009).  Therefore, it 
would seem reasonable to hypothesise that water-based exercise 
may be of significant benefit to patients with CHF due to the 
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added resistance of hydrostatic pressure in conjunction with the 
proposed haemodynamic benefits of warm-water immersion. 
Conversely, it has also been suggested that the immersion of 
patients with CHF in water may be detrimental to function, as 
the increase in hydrostatic pressure exerted on the body may 
increase the load on an already deficient cardiovascular system 
(Working Group on Cardiac, Rehabilitation, Exercise, Physiology, 
& Working Group on Heart Failure of the European Society of 
Cardiology).  However, recent evidence has shown that static 
warm water immersion leads to physiological responses in 
patients with CHF that include acute peripheral vasodilation, 
a reduction in peripheral resistance, and an increase in venous 
return (Gabrielsen et al 2000).  Svealv et al (2009) investigated 
the effect of an 8-week hydrotherapy programme on static 
physiological responses to warm water immersion in patients 
with chronic heart failure.  These authors found that static 
warm water immersion results in a significant acute reduction 
in peripheral resistance and heart rate with significant 
improvements in venous return and stroke volume.  However, 
these effects were neither significantly improved upon, nor 
maintained following 8 weeks of hydrotherapy exercise.
The main aim of cardiac rehabilitation programmes is to 
improve function, exercise tolerance and quality of life (NZ Heart 
Foundation 2009).  Exercise tolerance is commonly measured 
using the 6MWT as it is a valid, reliable, functional and clinically 
accessible outcome measure in this population (Shoemaker et 
al 2012). Exercise tolerance was investigated using the 6MWT 
in four studies included in this systematic review (Caminiti et al 
2009, Cider 2003, Cider et al 2012, Municino et al 2006).  Half 
of the studies included in this review achieved significant 6MWT 
improvements from baseline scores following a hydrotherapy 
exercise programme (Caminiti et al 2009, Cider et al 2012, 
Municino et al 2006).  The minimal clinically important difference 
(MCID) for the 6MWT for patients with CHF has been found to be 
40-45m (Shoemaker et al 2012) and the improvements recorded 
in the studies of both Munincino et al (2006) and Caminiti et al 
(2009) exceeded this.  It should be noted that both these studies 
had a greater number of exercise sessions (30 sessions and 72 
sessions, respectively), when compared with Cider et al (2003, 
2012), which each consisted of 24 sessions.  
Most studies also assessed exercise tolerance by measuring peak 
oxygen uptake (VO2peak) during an incremental cycle ergometer 
test (Cider et al 2003, Cider et al 2012, Mourot et al 2010, 
Municino et al 2006, Teffaha et al 2011).  VO
2peak
 is an important 
prognostic marker in patients with CHF (Myers et al 1998), given 
that a low VO
2peak
 in CHF patients is associated with increased 
mortality (Mancini et al 1991).  An increase in VO
2peak
 of 2 mL·kg-1· 
min-1 is considered to be clinically relevant in patients with severe 
CHF (van der Meer et al 2012).  The most promising results from 
the studies included in this review arose from Cider et al (2012), 
who found significant improvements in VO
2peak
 ( 2.1 mL·kg-1· 
min-1) compared to baseline following 8 weeks of water-based 
therapy.  It should be noted, however, that participants in this 
study had a lower VO
2peak
 at baseline compared to other studies 
included in this review.  This may be due to the participants 
having combined diagnoses of CHF and type II diabetes mellitus.  
A combination of CHF and type II diabetes mellitus is associated 
with a lower VO
2
 than in patients with only one of these diseases 
(Guazzi et al 2002).  This may mean that the participants in 
this study had an increased capacity for improvement following 
hydrotherapy intervention compared to other studies.
Patients with chronic health conditions suffer reductions in 
HRQOL compared with age-matched norms (Lee et al 2014).  
Exercise is a proven modality to significantly improve HRQOL 
in patients with chronic health conditions and, as such, is an 
important outcome to assess in any exercise intervention for 
chronic health conditions (Taylor et al 2014).  Interestingly, only 
half the included studies in this review investigated HRQOL 
(Cider et al 2003, Cider et al 2012, Municino et al 2006).  No 
significant differences in HRQOL between groups were found 
(Cider et al 2003, Cider et al 2012) but Cider (2003) and 
Municino (2006) found significant improvements in total scores 
from baseline using the disease-specific Minnesota Living with 
Heart Failure Questionnaire (MLHFQ).  Municino et al (2006) 
recorded a significant reduction in median scores (from 56 to 
18) after 3 weeks of water-based exercise.  This is a particularly 
important result given that the MCID for the MLHFQ is a 5-7 
point reduction on the overall score (Rector and Cohn 1992). 
It is important to note that this study also included a hydro-
massage relaxation therapy component along with a structured 
and supervised lifestyle change education component to the 
therapy programme.  Education aimed at improving self-
management and lifestyle modification has been shown to 
improve HRQOL in patients with CHF, and is recommended as 
an essential component in cardiac rehabilitation (Corra et al 
2005).  Therefore, this added component may have promoted 
patient reassurance and relaxation, leading to a greater sense of 
well-being and markedly improved results.
Differences in programme duration and intensity may have been a 
contributing factor to the variance in results across all studies.   It is 
possible that more significant results may have been elicited if some 
of the studies had been of a longer duration.  It has been suggested 
that a minimum of 8-12 weeks of exercise training is required to 
be effective (Piepoli et al 2010); the NZ Heart Foundation (2009) 
recommends a cardiac rehabilitation programme over 8 weeks for 
patients with CHF to allow for appropriate physiological adaptations 
to occur. All studies included in this review which were of three 
weeks duration or less failed to reach MCID figures for VO2peak, with 
mean results ranging from 1.5-1.8ml/kg improvements (Mourot et 
al 2010, Municino et al 2006, Teffaha et al 2011) and it is possible 
these studies may have met the MCID for VO
2peak
 if the programmes 
were longer in duration.
The intensity of exercise interventions may also have affected 
outcomes across all studies.  Many studies utilised a percentage 
of heart-rate reserve as a measure of intensity.  This method 
may be problematic in patients with CHF as they are commonly 
on beta-blocker medications (Di Franco et al 2013).  The role of 
beta-blockers is to reduce the effects of sympathetic nervous 
system activity on the myocardium, thereby reducing heart rate 
(Di Franco et al 2013).  As such, target heart rates may have 
been difficult for patients to achieve, given that beta-blockers 
prevent significant increases in heart rate.  It has been found 
that exertion scales such as the Borg Rating of Perceived Exertion 
correlate well with VO
2peak
 in patients with CHF, even in those 
using beta-blockers (Levinger et al 2004).  Using an exertion scale 
may therefore be a useful tool to prescribe, monitor intensity and 
ensure appropriate progression of exercise in patients with CHF. 
Based on the evidence found in this review, hydrotherapy appears 
to be a safe, accessible and well-tolerated form of exercise, with 
no adverse events reported across any of the included studies.  
Importantly, adherence was high with only one reported withdrawal 
across all studies.  This completion rate is well above the average for 
cardiac rehabilitation, with up to 37% of people failing to complete 
programmes (Carvalho and Guimaraez 2010). This may prove to be 
a major benefit of hydrotherapy, as there have been many reported 
barriers to adhering to land based exercise programmes in patients 
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with CHF, including being “painful, “tiresome” and “boring” 
(Conraads et al 2012).  Therefore, if hydrotherapy proves to be as 
effective as land-based exercise and is better tolerated, it may be 
a mechanism for overcoming barriers, improving attendance and 
improving rehabilitation outcomes for people living with CHF.
CONCLUSION 
In the present systematic review, we identified six studies 
comparing hydrotherapy versus no exercise or land-based exercise 
training in people with stable chronic heart failure (CHF) of NYHA 
II-III.  There was significant variability in the reporting, components 
and length of the water-based interventions undertaken by each 
of the studies.  This may account for the variability in exercise 
tolerance and HRQOL outcomes across all the studies.  The 
quality of available evidence overall was of poor to moderate 
quality according to the Downs and Black criteria; and therefore 
further research of higher methodological quality is required 
before strong recommendations can be made regarding the 
effect of aquatic-based exercise on exercise tolerance and HRQOL 
in patients with stable CHF.  Such research should include the 
evaluation of water-based exercise compared with equivalent 
land-based activities, of appropriate duration and intensity.
KEY POINTS
•  Hydrotherapy appears to be a safe and well tolerated exercise 
intervention in patients with CHF of NYHA II-III. 
•  Hydrotherapy appears to improve exercise tolerance and health 
related quality of life in patients with CHF of NYHA II-III.
•  Further high-quality research is required before strong 
conclusions can be drawn on the effectiveness of 
hydrotherapy for patients with CHF.
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APPENDIX A: Key words used in search databases
Key words “OR”
Hydrotherap* “immersion-therap*” “water-based”
“Aquatic exercise” Balenotherap* “water gymnastic*”
Thalassotherapy “water aerobic*” Kneipp
“aqua therap*” “pool therap*” Aquatic*
Key words “AND”
“Heart failure” “chronic heart” “congestive heart”
“ventricular dysfunction” CHF “heart dysfunction”
“heart disease”
Note: *Truncation symbol 
APPENDIX B: Selection criteria for studies to be included in critique 
Study Selection Criteria
In English language
Randomised controlled trials and quasi-experimental studies
Outcome measures: any exercise-related and HRQOL outcome measures
Publication dates between year 1995-2014
Subjects: Humans, >18-years-old, diagnosed with CHF
Intervention: Hydrotherapy
Study Exclusion Criteria
Systematic and/or literature reviews
Immersion only (no exercise/movement in water)

